Authors: LAZER ES SORCEK R CYWIN CL THOME D POSSANZA GJ GRAHAM AG CHURCHILL L

Citation: Es. Lazer et al., ANTIINFLAMMATORY 2-BENZYL-4-SULFONYL-4H-ISIOQUINOLINE-1,3-DIONES - NOVEL INHIBITORS OF COX-2, Bioorganic & medicinal chemistry letters, 8(10), 1998, pp. 1181-1186

Authors: LAZER ES MIAO CK CYWIN CL SORCEK R WONG HC MENG ZX POTOCKI I HOERMANN M SNOW RJ TSCHANTZ MA KELLY TA MCNEILL DW COUTTS SJ CHURCHILL L GRAHAM AG DAVID E GROB PM ENGEL W MEIER H TRUMMLITZ G

Citation: Es. Lazer et al., EFFECT OF STRUCTURAL MODIFICATION OF ENOL-CARBOXAMIDE-TYPE NONSTEROIDAL ANTIINFLAMMATORY DRUGS ON COX-2 COX-1 SELECTIVITY/, Journal of medicinal chemistry, 40(6), 1997, pp. 980-989

Authors: FARINA PR GRAHAM AG HOFFMAN AF WATROUS JM BORGEAT P NADEAU M HANSEN G DINALLO RM ADAMS J MIAO CK LAZER ES PARKS TP HOMON CA

Citation: Pr. Farina et al., BIRM-270 - A NOVEL INHIBITOR OF ARACHIDONATE RELEASE THAT BLOCKS LEUKOTRIENE B-4 AND PLATELET-ACTIVATING-FACTOR BIOSYNTHESIS IN HUMAN NEUTROPHILS, The Journal of pharmacology and experimental therapeutics, 271(3), 1994, pp. 1418-1426

Authors: LAZER ES MIAO CK WONG HC SORCEK R SPERO DM GILMAN A PAL K BEHNKE M GRAHAM AG WATROUS JM HOMON CA NAGEL J SHAH A GUINDON Y FARINA PR ADAMS J

Citation: Es. Lazer et al., BENZOXAZOLAMINES AND BENZOTHIAZOLAMINES - POTENT, ENANTIOSELECTIVE INHIBITORS OF LEUKOTRIENE BIOSYNTHESIS WITH A NOVEL MECHANISM OF ACTION, Journal of medicinal chemistry, 37(7), 1994, pp. 913-923

Authors: WEGNER CD GUNDEL RH ABRAHAM WM SCHULMAN ES KONTNY MJ LAZER ES HOMON CA GRAHAM AG TORCELLINI CA CLARKE CC JAGER P WOLYNIEC WW LETTS LG FARINA PR

Citation: Cd. Wegner et al., THE ROLE OF 5-LIPOXYGENASE PRODUCTS IN PRECLINICAL MODELS OF ASTHMA, Journal of allergy and clinical immunology, 91(4), 1993, pp. 917-929

Authors: FARINA PR GRAHAM AG HOMON CA LAZER ES HATTOX SE RISKA PS GUNDEL RH WEGNER CD

Citation: Pr. Farina et al., A PRODRUG OF A 2,6-DISUBSTITUTED 4-(2-ARYLETHENYL)PHENOL IS A SELECTIVE AND ORALLY ACTIVE 5-LIPOXYGENASE INHIBITOR, The Journal of pharmacology and experimental therapeutics, 265(2), 1993, pp. 483-489